Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overall survival and final efficacy and safety results from a Japanese phase II study of axitinib in cytokine-refractory metastatic renal cell carcinoma.
Eto M, Uemura H, Tomita Y, Kanayama H, Shinohara N, Kamei Y, Fujii Y, Umeyama Y, Ozono S, Naito S, Akaza H; Japan Axitinib Phase II Study Group. Eto M, et al. Cancer Sci. 2014 Dec;105(12):1576-83. doi: 10.1111/cas.12546. Epub 2014 Nov 25. Cancer Sci. 2014. PMID: 25283266 Free PMC article. Clinical Trial.
A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy.
Yoh K, Hosomi Y, Kasahara K, Yamada K, Takahashi T, Yamamoto N, Nishio M, Ohe Y, Koue T, Nakamura T, Enatsu S, Lee P, Ferry D, Tamura T, Nakagawa K. Yoh K, et al. Among authors: nakamura t. Lung Cancer. 2016 Sep;99:186-93. doi: 10.1016/j.lungcan.2016.07.019. Epub 2016 Jul 18. Lung Cancer. 2016. PMID: 27565938 Free article. Clinical Trial.
A phase I dose-escalation study of LY2875358, a bivalent MET antibody, given as monotherapy or in combination with erlotinib or gefitinib in Japanese patients with advanced malignancies.
Yoh K, Doi T, Ohmatsu H, Kojima T, Takahashi H, Zenke Y, Wacheck V, Enatsu S, Nakamura T, Turner K, Uenaka K. Yoh K, et al. Among authors: nakamura t. Invest New Drugs. 2016 Oct;34(5):584-95. doi: 10.1007/s10637-016-0370-7. Epub 2016 Sep 1. Invest New Drugs. 2016. PMID: 27422720 Free PMC article. Clinical Trial.
Changes in systolic blood pressure during hospitalisation and bleeding events after percutaneous coronary intervention.
Otsuka Y, Ishii M, Ikebe S, Nakamura T, Tsujita K, Matoba T, Kohro T, Oba Y, Kabutoya T, Kario K, Imai Y, Kiyosue A, Mizuno Y, Nochioka K, Nakayama M, Iwai T, Miyamoto Y, Sato H, Akashi N, Fujita H, Nagai R. Otsuka Y, et al. Among authors: nakamura t. Open Heart. 2024 Dec 23;11(2):e002987. doi: 10.1136/openhrt-2024-002987. Open Heart. 2024. PMID: 39719275 Free PMC article.
Protocol of randomized-controlled trial to examine the effectiveness of three different interventions to reduce healthcare provider burnout.
Ruple C, Brodhead J, Rabinovich L, Junghaenel DU, Nakamura T, Wong J, De-Oliveira S, Brown J, Nguyen P, Horn J, Middleton R, Brahe M, Wen C, Rao S, Nguyen C, Shlamovitz G, Marino D, Osorno F, Siegel S. Ruple C, et al. Among authors: nakamura t. BMC Health Serv Res. 2024 Dec 23;24(1):1643. doi: 10.1186/s12913-024-12131-4. BMC Health Serv Res. 2024. PMID: 39716202 Free PMC article. Clinical Trial.
17,292 results
You have reached the last available page of results. Please see the User Guide for more information.